Sponsored Symposia

Treatment decision-making in invasive candidiasis: The Science and The Art

  Participantes: Arnaldo Colombo e Fabianne Carlesse

From Guidelines to Practice: Incorporating Rezafungin into the Management of Invasive Candidiasis

Moderator: Arnaldo Colombo

• 12:10 – 12:20 Unmet Needs and Emerging Challenges in Invasive Candidiasis in Brazil Speaker: Arnaldo Colombo
• 12:20 – 12:40 Advancing Treatment with Rezafungin in Critically Ill and Intra-abdominal Infections Speaker: Paula Peçanha
• 12:40 – 13:00 Rezafungin in Practice: Optimizing Care in OPAT and Specialized Populations Speaker: Vinícius Ponzio
• 13:00 – 13:10 Q&A All speakers

Echinocandin in personalized antifungal therapy in hematology

  Participantes: Marcia Garnica e Vinicius Ponzio

Tackling fungal resistance with MICRONAUT-AM – Bruker’s EUCAST-based AFST Solution

  Speaker: Robert Hoenings

Evidence, Experiences, and Real Challenges in the Treatment of Invasive Aspergillosis and Mucormycoses

Chair: Ana Verena Almeida Mendes
Speakers: Alessandro Pasqualotto, Marcia Garnica e Filipe Prohaska

IMMY Sponsored Symposium

Chairs: Luisa F. Lopez (USA) e Mariana Andreani (Argentina)

• 16:40 – 17:00 Diagnostic algorithms for pneumonias in the diagnosis of dimorphic mycoses Dalla Smith (USA)
• 17:00 – 17:20 Usefulness of the positive Aspergillus galactomannan Lateral Flow Assay report as an early warning call in a hospital in Mexico Daniel Aguillar (Mexico)
• 17:20 – 17:40 Predicting Cryptococcal meningitis using a serum CrAg SQ LFA in patients with advanced HIV Emmanuel Marin (Argentina)
• 17:40 – 18:00 Final discussion

Invasive Fungal Infections in Immunocompromised Patients: From Risk Stratification to Therapeutic Decision-Making

Chair: Eduardo Ditzel

• 10:00 – 10:15 Febrile Neutropenia: Risk Stratification, Guidelines, and Management of Immunocompromised Patients Speaker: Jéssica Ramos
• 10:15 – 10:30 Liposomal Amphotericin B: What Does the Literature Say to Date? Speaker: Diego Rodrigues Falci
• 10:30 – 10:45 L-AmB Generics: Nanosimilars or Pseudo-liposomes? The Challenge of Biopharmaceutical Fidelity to the Reference Product Speaker: Francelise Cavassin
• 10:45 – 11:00 Discussion